Comparison of Two Multi-Purpose Solution and Lens Material Combinations on Corneal Barrier Function

NCT ID: NCT00560898

Last Updated: 2008-05-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-09-30

Study Completion Date

2008-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to measure the relative "barrier" function of the top layer of the cornea (called the epithelium), or the degree to which the cornea can prevent the penetration of the colored dye sodium fluorescein into the eye. This is a clinical investigation of the effect on corneal barrier function following wear of two contact lens materials and two contact lens care systems, approved for marketing in the US by the Food and Drug Administration. These contact lenses will be worn for two hours, following soak in one of two marketed contact lens disinfecting solutions. Approximately 25 young, adapted contact lens wearers will participate.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contact Lens Disinfecting Solutions

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

staining epithelial barrier function

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

2

contact lenses disinfected in multipurpose solution

Group Type EXPERIMENTAL

ProClear Lens Material soaked in ReNu Multiplus Multipurpose Solution

Intervention Type DRUG

Contact lens soaked in multipuprpose solution for 8 hours, then worn for two hours

3

contact lenses disinfected in multipurpose solution

Group Type EXPERIMENTAL

Acuvue Advance Lens Material soaked in ReNu Multiplus Multipurpose Solution

Intervention Type DRUG

Contact lens soaked in multipuprpose solution for 8 hours, then worn for two hours

4

contact lenses disinfected in multipurpose solution

Group Type EXPERIMENTAL

Acuvue Advance Lens Material soaked in Optifree RepleniSH Multipurpose Solution

Intervention Type DRUG

Contact lens soaked in multipuprpose solution for 8 hours, then worn for two hours

1

contact lenses disinfected in multipurpose solution

Group Type EXPERIMENTAL

ProClear Lens Material soaked in Optifree RepleniSH Multipurpose Solution

Intervention Type DRUG

Contact lens soaked in multipuprpose solution for 8 hours, then worn for two hours

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ProClear Lens Material soaked in ReNu Multiplus Multipurpose Solution

Contact lens soaked in multipuprpose solution for 8 hours, then worn for two hours

Intervention Type DRUG

Acuvue Advance Lens Material soaked in ReNu Multiplus Multipurpose Solution

Contact lens soaked in multipuprpose solution for 8 hours, then worn for two hours

Intervention Type DRUG

Acuvue Advance Lens Material soaked in Optifree RepleniSH Multipurpose Solution

Contact lens soaked in multipuprpose solution for 8 hours, then worn for two hours

Intervention Type DRUG

ProClear Lens Material soaked in Optifree RepleniSH Multipurpose Solution

Contact lens soaked in multipuprpose solution for 8 hours, then worn for two hours

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 18 years of age.

* Understand your rights as a research subject and give written informed consent by signing the Informed Consent Form, Subject Bill of Rights, and Patient Authorization for Use and Release of Health and Research Study Information (HIPAA form).
* Be likely to finish the entire study, understand the study instructions, and be willing to follow the instructions.
* Contact lens prescription between +4.00 D to -9.00 D (spherical equivalent).
* Best correctable visual acuity of at least 20/40 in each eye.
* Willing to de-adapt (do not wear) from habitual contact lenses for periods of three days prior to barrier function determination.
* Possess a functional spectacle prescription to allow adequate vision during the de-adaptation and barrier function determination periods.
* No known ocular or systemic allergies, which may interfere with contact lens wear.
* No known systemic disease, or need for medication that may interfere with contact lens wear (i.e. antihistamines, beta-blockers, steroids).

Exclusion Criteria

* Subjects demonstrating any medical condition that may affect the results of this study SHOULD NOT be enrolled. The following are specific conditions that exclude subjects from enrollment in this study.

* Eye (ocular) or systemic allergies that may interfere with contact lens wear.
* Less than one month successful, full time (defined as more than 8 hours per day, and more than 5 days per week) soft lens wear.
* Systemic disease or uses of medication, which may interfere with contact lens wear.
* Clinically significant corneal swelling (greater than grade 3 or 4 on a 0-4 scale), corneal blood vessel growth) (vascularization), corneal staining, bulbar redness, tarsal redness, or any other abnormality of the cornea that may cause unsafe contact lens wear.
* Any active ocular infection.
* Prior corneal refractive surgery (i.e., LASIK, PRK, etc).
* Have used medications within 24 hours of study entry or have an ongoing need to use ocular medication.
* Are taking part in any other study or have taken part in a study within the last 14 days
* Have a medical condition that your study eye doctor thinks may make it not appropriate for you to participate in this study.
* Are pregnant, or anticipate becoming pregnant during the course of this study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role collaborator

Southern California College of Optometry at Marshall B. Ketchum University

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jerry R Paugh, OD, PhD

Role: PRINCIPAL_INVESTIGATOR

Southern California College of Optometry at Marshall B. Ketchum University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Southern California College of Optometry

Fullerton, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

00001418

Identifier Type: -

Identifier Source: secondary_id

00001418

Identifier Type: -

Identifier Source: org_study_id